|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 311.20 SEK | -0.89% |
|
-3.60% | +0.06% |
| 14/07 | Bioarctic: LEADER study shows more than 82 percent of Leqembi patients remained stable or improved | FW |
| 14/07 | Leqembi can now be administered at home from the start of treatment in the US | FW |
- Stock Market
- Stocks
- BIOA B Stock
- Charts BioArctic AB
- Static Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















